Related Experiment Video
Updated: Apr 6, 2026

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
Different binding and recognition modes of GL479, a dual agonist of Peroxisome Proliferator-Activated Receptor α/γ
Jademilson Celestino dos Santos1, Amanda Bernardes1, Letizia Giampietro2
1Grupo de Biotecnologia Molecular, Instituto de Física de São Carlos, Universidade de São Paulo, São Carlos, SP 13566-590, Brazil.
Abstract:
Peroxisome Proliferator-Activated Receptors (PPARs) are ligand-dependent transcription factors that control various functions in human organism, including the control of glucose and lipid metabolism. PPARγ is a target of TZD agonists, clinically used to improve insulin sensitivity whereas fibrates, PPARα ligands, lower serum triglyceride levels. We report here the structural studies of GL479, a synthetic dual PPARα/γ agonist, designed by a combination of clofibric acid skeleton and a phenyldiazenyl moiety, as bioisosteric replacement of stilbene group, in complex with both PPARα and PPARγ receptors. GL479 was previously reported as a partial agonist of PPARγ and a full agonist of PPARα with high affinity for both PPARs. Our structural studies reveal different binding modes of GL479 to PPARα and PPARγ, which may explain the distinct activation behaviors observed for each receptor. In both cases the ligand interacts with a Tyr located at helix 12 (H12), resulting in the receptor active conformation. In the complex with PPARα, GL479 occupies the same region of the ligand-binding pocket (LBP) observed for other full agonists, whereas GL479 bound to PPARγ displays a new binding mode. Our results indicate a novel region of PPARs LBP that may be explored for the design of partial agonists as well dual PPARα/γ agonists that combine, simultaneously, the therapeutic effects of the treatment of insulin resistance and dyslipidemia.
Insights
Dual Peroxisome Proliferator-Activated Receptor (PPAR) agonists like GL479 show distinct binding modes in PPARα and PPARγ receptors. These structural insights may guide the development of new treatments for insulin resistance and dyslipidemia.
Area of Science:
- Biochemistry
- Structural Biology
- Pharmacology
Background:
- Peroxisome Proliferator-Activated Receptors (PPARs) are crucial transcription factors regulating glucose and lipid metabolism.
- PPARγ agonists (TZDs) improve insulin sensitivity, while PPARα ligands (fibrates) reduce triglycerides.
- GL479 is a synthetic dual PPARα/γ agonist with high affinity for both receptors.
Purpose of the Study:
- To elucidate the structural basis of GL479's dual agonism by studying its complexes with PPARα and PPARγ.
- To understand how GL479's distinct binding modes influence its activation of PPARα versus PPARγ.
- To identify novel regions within the PPAR ligand-binding pocket for future drug design.
Main Methods:
- X-ray crystallography was used to determine the structures of GL479 in complex with PPARα and PPARγ.
- Comparative analysis of the ligand-binding pocket occupancy and interactions in both receptor complexes.
- Assessment of GL479's previously reported partial PPARγ and full PPARα agonist activities.
Main Results:
- GL479 exhibits different binding modes when complexed with PPARα and PPARγ.
- In both receptors, GL479 interacts with a tyrosine residue in helix 12, stabilizing the active conformation.
- GL479 occupies a canonical pocket in PPARα but a novel region in PPARγ.
Conclusions:
- The distinct structural interactions of GL479 with PPARα and PPARγ explain its differential activation profiles.
- The findings reveal a previously unexplored region of the PPAR ligand-binding pocket.
- This structural understanding can inform the design of novel partial and dual PPAR agonists for treating metabolic disorders.
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Oral Hypoglycemic Agents: Glinides
GPCRs Regulate Adenylyl Cylase Activity
Dipeptidyl Peptidase 4 Inhibitors
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...

